...
Partnership Update – Any positive update on the partnership with CC Pharming has the potential to send this stock through the roof.
Vaccine Development – At some point, it’s likely that the company will announce that it has developed a viable vaccine candidate in its partnership and is pushing the candidate into clinical trials. This could also send the stock soaring.
Manufacturing Partnerships – IBIO and CC Pharming aren’t the only companies working to develop a coronavirus vaccine out there. In fact, there are tons of them. However, iBio is the only company with access to the FastPharming Facility. So, we could start to hear more about potential manufacturing partnerships with other vaccine developers.
Funding – Recently, the United States government passed a bill to provide $8 billion in funding to fight the spread of the Wuhan coronavirus. Considering the competitive advantages here, IBIO is a likely recipient of some of these funds. Soon, I expect that the company will announce the receipt of funds as part of this program, sending the stock skyward...
alphastocknews.com/...tock-catalysts-to-watch-for-ahead/2740/